Sotabase

Career

· Associate Professor, Indian Institute of Technology, Madras2022–
· Asst. Professor, IIT Madras (Current)2012–
· Postdoc, LRI, University of Paris Sud, Orsay, France2011–2012
· Postdoctoral Fellow, National Taiwan University2010–2011
· Asst. Professor, C R Rao AIMSCS, Hyderabad2009–2010
· Postdoctor, IISc, Bangalore2009–2009
· Doctor of Philosophy (Ph.D.), Mathematics and Computer Science, The Institute of Mathematical Sciences, Chennai2003–2008
· Graduate student, Theoretical Computer Science, Tata Institute of Fundamental Research, Mumbai2001–2003
· M.Sc., Operations Research and Computer Applications, Cochin University of Science and Technology1997–2000
· SSLC, Govt. High School Poonkunnam, Trichur1990–1992

Publications (120)

Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice
International Journal of Cancer · 2009
344
cited
Docosahexaenoic acid regulated genes and transcription factors inducing apoptosis in human colon cancer cells.
International Journal of Oncology · 2001
197
cited
Modulation of inducible nitric oxide synthase and related proinflammatory genes by the omega-3 fatty acid docosahexaenoic acid in human colon cancer cells.
Cancer Research · 2003
182
cited
Differential expression of genes induced by resveratrol in LNCaP cells: P53‐mediated molecular targets
International Journal of Cancer · 2003
168
cited
Regression of Mouse Prostatic Intraepithelial Neoplasia by Nonsteroidal Anti-inflammatory Drugs in the Transgenic Adenocarcinoma Mouse Prostate Model
Clinical Cancer Research · 2004
124
cited
A pilot, randomized, double‐blind, placebo‐controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee
Phytotherapy Research · 2019
111
cited
Effects of a combination of docosahexaenoic acid and 1,4-phenylene bis(methylene) selenocyanate on cyclooxygenase 2, inducible nitric oxide synthase and beta-catenin pathways in colon cancer cells.
Carcinogenesis · 2004
88
cited
A combination of docosahexaenoic acid and celecoxib prevents prostate cancer cell growth in vitro and is associated with modulation of nuclear factor-kappaB, and steroid hormone receptors.
International Journal of Oncology · 2005
86
cited
Suppression of N-methyl-N-nitrosourea/testosterone-induced rat prostate cancer growth by celecoxib: effects on cyclooxygenase-2, cell cycle regulation, and apoptosis mechanism(s).
Clinical Cancer Research · 2003
74
cited
Adenocarcina of the mouse prostate growth inhibition by celecoxib: Downregulation of transcription factors involved in COX‐2 inhibition
The Prostate · 2006
69
cited
Interactive gene expression pattern in prostate cancer cells exposed to phenolic antioxidants.
Life Science · 2002
64
cited
RNA interference–mediated cyclooxygenase-2 inhibition prevents prostate cancer cell growth and induces differentiation: modulation of neuronal protein synaptophysin, cyclin D1, and androgen receptor
Molecular Cancer Therapeutics · 2006
53
cited
Antitumor activity of melinjo (Gnetum gnemon L.) seed extract in human and murine tumor models in vitro and in a colon-26 tumor-bearing mouse model in vivo
Cancer Medicine · 2015
51
cited
Resveratrol-induced cell growth inhibition and apoptosis is associated with modulation of phosphoglycerate mutase B in human prostate cancer cells: two-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis and mass spectrometry evaluation.
Cancer Detection and Prevention · 2004
46
cited
Docosahexaenoic acid in combination with celecoxib modulates HSP70 and p53 proteins in prostate cancer cells
International Journal of Cancer · 2006
45
cited
Proline-rich AKT substrate of 40-kDa (PRAS40) in the pathophysiology of cancer.
Biochemical and Biophysical Research Communications - BBRC · 2015
44
cited
IND-2, a pyrimido[1″,2″:1,5]pyrazolo[3,4-b]quinoline derivative, circumvents multi-drug resistance and causes apoptosis in colon cancer cells.
Bioorganic & Medicinal Chemistry · 2015
39
cited
Molecular targets of the chemopreventive agent 1,4-phenylenebis (methylene)-selenocyanate in human non-small cell lung cancer.
Carcinogenesis · 2006
39
cited
Elucidation of molecular targets of mammary cancer chemoprevention in the rat by organoselenium compounds using cDNA microarray.
Carcinogenesis · 2003
37
cited
Exisulind in Combination with Celecoxib Modulates Epidermal Growth Factor Receptor, Cyclooxygenase-2, and Cyclin D1 against Prostate Carcinogenesis: In vivo Evidence
Clinical Cancer Research · 2007
36
cited
Sotabase
Narayanan 'Narv' Narayanan | Researcher Profile | Sotabase | Sotabase